SooRang Lee - CU Medical Managing Director
| 115480 Stock | KRW 640.00 1.00 0.16% |
Insider
SooRang Lee is Managing Director of CU Medical Systems
| Age | 60 |
| Phone | (82) 31 421 9911 |
| Web | www.cu911.com |
CU Medical Management Efficiency
The company has return on total asset (ROA) of (0.0377) % which means that it has lost $0.0377 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.7908) %, meaning that it generated substantial loss on money invested by shareholders. CU Medical's management efficiency ratios could be used to measure how well CU Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| YongIn Kim | Medy Tox | 61 | |
| Kim Kyoon | UNISEM Co | 64 | |
| Sung Lee | Genexine | N/A | |
| Kyu Kim | Genexine | N/A | |
| WooSun Lee | Medy Tox | 46 | |
| Cho Bum | UNISEM Co | 61 | |
| Lopez Michael | Medy Tox | 62 | |
| Sung CPA | Genexine | N/A | |
| Jae Park | Genexine | N/A | |
| You Suh | Genexine | N/A | |
| Young Sung | Genexine | 67 | |
| SeungBum Park | Medy Tox | 54 | |
| KiHyuk Yang | Medy Tox | 54 | |
| Lee Koo | UNISEM Co | 61 | |
| Jungwon Woo | Genexine | N/A | |
| JaiHyun Kwon | Genexine | N/A | |
| HyunHo Jung | Medy Tox | 61 | |
| HeeSeok Joo | Medy Tox | 57 | |
Management Performance
| Return On Equity | -4.79 | |||
| Return On Asset | -0.0377 |
CU Medical Systems Leadership Team
Elected by the shareholders, the CU Medical's board of directors comprises two types of representatives: CU Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 115480. The board's role is to monitor CU Medical's management team and ensure that shareholders' interests are well served. CU Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CU Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| SooRang Lee, Managing Director | ||
| ShinHee Kang, Managing Director | ||
| Gyeong Kim, Internal Auditor | ||
| Su Lee, Assistant Managing Director | ||
| Sin Kang, Director | ||
| Seong Choi, Director | ||
| Hak Nah, Chief Executive Officer, Director | ||
| Yeong Park, Non-Executive Independent Director | ||
| HyungSoo Kim, Chief Officer |
115480 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CU Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.79 | |||
| Return On Asset | -0.0377 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.23) % | |||
| Current Valuation | 60.56 B | |||
| Shares Outstanding | 15.89 M | |||
| Shares Owned By Insiders | 7.20 % | |||
| Price To Sales | 0.50 X | |||
| Revenue | 35.4 B | |||
| Gross Profit | 12.39 B |
Pair Trading with CU Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CU Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CU Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CU Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CU Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CU Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CU Medical Systems to buy it.
The correlation of CU Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CU Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CU Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CU Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 115480 Stock
CU Medical financial ratios help investors to determine whether 115480 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 115480 with respect to the benefits of owning CU Medical security.